Quest for the cure. Newsletter 2020 – Issue 2; Business Update - Hamlet Pharma receives EU grant for €2.2M
Last month, members of the Hamlet Pharma Executive Team travelled to Brussels in order to make a formal presentation of its grant request, Alpha 1H – A Unique Bladder Cancer Therapeutic, Acting with Great Precision, to the European Commission, Horizon 2020 – Research and Innovation Framework Programme. This is an extremely competitive programme, where innovators and business from all industries and backgrounds from across Europe, fight for funding with which to drive their respective visions further.We are extremely pleased and proud to announce that Hamlet Pharma’s grant application not